GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (OSTO:IMP A SDB) » Definitions » Total Equity

Implantica AG (OSTO:IMP A SDB) Total Equity : kr0.00 Mil (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Total Equity?

Implantica AG's total equity for the quarter that ended in . 20 was kr0.00 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Implantica AG Total Equity Historical Data

The historical data trend for Implantica AG's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Total Equity Chart

Implantica AG Annual Data
Trend
Total Equity

Implantica AG Semi-Annual Data
Total Equity

Implantica AG Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Implantica AG's Total Equity for the fiscal year that ended in . 20 is calculated as

Total Equity=Total Assets(Q: . 20 )-Total Liabilities(Q: . 20 )
=N/A-N/A
=N/A

Implantica AG's Total Equity for the quarter that ended in . 20 is calculated as

Total Equity=Total Assets(Q: . 20 )-Total Liabilities(Q: . 20 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Implantica AG Total Equity Related Terms

Thank you for viewing the detailed overview of Implantica AG's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Implantica AG Business Description

Comparable Companies
Traded in Other Exchanges
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Implantica AG Headlines

No Headlines